#USA #New York #Semler Scientific #Levi Korsinsky #Lead Plaintiff

Overview

Levi & Korsinsky, LLP has recently notified investors of a crucial development concerning Semler Scientific, Inc. (NASDAQ: SMLR), specifically regarding a class action securities lawsuit. Shareholders need to take note of the approaching lead plaintiff deadline, which is set for October 28, 2025. This announcement is especially important for those who may have incurred losses related to investments during the period of alleged securities fraud that spans from March 10, 2021 to April 15, 2025.

The Nature of the Lawsuit

The securities lawsuit aims to hold accountable those responsible for making false statements and possibly concealing significant information that could have influenced shareholder decisions. According to the complaint, Semler Scientific was alleged to have not disclosed an active investigation by the U.S. Department of Justice regarding possible violations of the False Claims Act. During discussions about such potential violations, the company reportedly spoke in hypothetical terms without disclosing critical facts.

As a result of these actions, the public statements made by Semler were considered materially misleading, exposing investors to significant financial risks. This brings forth the legal grounds upon which shareholders can claim damages due to misleading information that directly impacted their investment choices.

Shareholder Rights and Options

If you are an investor who suffered losses in Semler Scientific shares during the designated timeframe, it is imperative to act quickly. The October deadline is your opportunity to request that the court appoint you as the lead plaintiff in this case. However, it's important to note that participating in the lawsuit or being appointed as a lead plaintiff is not a prerequisite to share in any potential recoveries that may arise from the case.

Typically, as a class member, there may not be any out-of-pocket costs for involvement. This means eligible shareholders could potentially be compensated without needing to cover legal expenses upfront. Thus, filing a claim within the stipulated timeframe is highly encouraged, as it could result in financial recovery, depending on the outcome of the case.

Why Choose Levi & Korsinsky?

Levi & Korsinsky boasts a proven track record, having represented aggrieved shareholders for over two decades. Their team has secured hundreds of millions of dollars in settlements and has been recognized multiple times in the ISS Securities Class Action Services' Top 50 Report as a leading securities litigation firm in the United States. This solidifies their expertise in handling complex securities cases and serves as an assurance to potential clients of their commitment and capabilities.

Contact Information

For additional information or guidance, interested Semler Scientific investors are advised to contact the firm directly. Joseph E. Levi, Esq. can be reached via email at [email protected] or by phone at (212) 363-7500. Alternatively, detailed information about the lawsuit can be accessed through the link provided in the original announcement.

Conclusion

The deadline of October 28, 2025, serves as a critical date for shareholders of Semler Scientific, Inc. Any affected investors are urged to take proactive steps to safeguard their interests and explore their legal rights by connecting with Levi & Korsinsky. The unfolding of this case could have substantial implications on their financial recovery options.